Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 1583 - файл
.pdf
The field of transplant surgeryis guided byseveral fundamental principles that ensure the success of
organ transplantation, minimize complications, and provide long-term survival for recipients. These
principles include the selection of appropriate donors and recipients, ensuring immunological
compatibility,andemployingstrategiestopreventorganrejection.
16.1.1TypesofOrganTransplantation
Organtransplantationisclassifiedintodifferentcategoriesbasedonthesourceofthedonororgan.These
categoriesinclude:
Living Donor Transplants: In some cases, healthy individuals may donate a kidney, a
portionof their liver,or othertissues to a recipientinneed.Livingdonor transplantsare
advantageousduetobetterorganquality,shorterwaitingtimes,andlowerrisksofdelayed
graftfunction.Kidneyandlivertransplantsarethemostcommonproceduresinvolvingliving
donors.
DeceasedDonorTransplants: Deceaseddonors, oftenindividuals whohave experienced
braindeath,provideorganssuchastheheart,lungs,liver,kidneys,andpancreas.Deceased
donor transplantsrequire theorgantobe harvested soonafterdeathtoensure viability. A
majorchallengeindeceaseddonortransplantsisthelimitedsupplyoforgans,whichleads
tolengthywaitinglistsforrecipients.
Autografts: This type of transplant involves the transfer of tissues from one part of a
person'sbodytoanotherpart.Skingraftsandvasculargraftsareexamplesofautograftsand
areoftenusedinreconstructivesurgeries.
Allografts: Allografts involve the transplantation of organs or tissues between two
geneticallynon-identicalindividualsofthesamespecies.Thisisthemostcommontypeof
transplantation and includes heart, liver, and kidney transplants. Immunological
compatibilityisamajorconcerninallografts.
Xenografts:Xenotransplantationinvolvesthetransferoforgansortissuesbetweendifferent
species, such as using pigorgans for transplantationintohumans. This is anexperimental
field with significant challenges, including rejection and zoonotic infections, though
advancementsingeneticengineeringhaverevivedinterestinxenotransplantation.
16.1.2OrganDonationandAllocation
Organ transplantation relies on a fair and ethical system of organ allocation, which is governed by
nationalandinternationalregulatorybodies.Theallocationoforgansisbasedoncriteriasuchasmedical
urgency, tissuecompatibility, andtime onthewaitinglist. In many countries, specializedorganizations
managethedonationanddistributionoforgans.IntheUnitedStates,forinstance,theUnitedNetworkfor
OrganSharing(UNOS) oversees organallocation,ensuringthat patients receive organs in a fair and
timelymanner.
16.1.3ImmunologicalCompatibility
One of the greatest challenges in organ transplantation is the risk of rejection, where the recipient’s
immunesystemidentifiesthetransplantedorganasforeignandmountsanimmuneresponsetodestroyit.
Topreventthis,theconceptofimmunologicalcompatibilityiscentralintheselectionofbothdonorand
recipient.Severalkeyfactorsmustbeconsidered:
https://t.me/med1917
ABO Blood Group Compatibility: Matching the donor’s and recipient’s blood types is
essential in reducing the riskof hyperacute rejection. While blood group matching is not
alwaysrequiredforeveryorgan,itiscriticalforkidneyandhearttransplants.
Human Leukocyte Antigen (HLA) Typing: HLA molecules are proteins present on the
surface of most cells in the body and play a critical role in immune recognition. HLA
matchingbetweenthedonorandrecipient,particularlyforkidneytransplants,isimportantin
reducingtheriskofacuteandchronicrejection.
Panel Reactive Antibodies (PRA): PRA testing measures the level of antibodies a
recipienthasagainstHLAantigens.RecipientswithhighPRAlevelsareatincreasedriskof
rejection,makingitmoredifficulttofindasuitablematch.
Crossmatching: Crossmatching is a laboratory test performed to determine whether the
recipient’simmunesystem haspreformed antibodies against the donor’scells. A positive
crossmatchindicatesahighriskofrejection,andthetransplantisgenerallynotperformedin
suchcases.
16.1.4OrganPreservationandTransport
Thesuccessoforgantransplantationisheavilydependentonthepreservationandtransportoftheorgan
from the donor to the recipient. Once harvested, organs must be kept in a cold, oxygen-deprived
environment to slow down cellular metabolism and prevent ischemia. Specialized solutions, such as
University of Wisconsin solution (UW solution), are used to preserve the organ’s viability during
transport.
ColdIschemiaTime(CIT):Thetimeanorganremainsoutsidethebodyinacooledstateis
known as thecold ischemia time. For most organs,shorter CITis associated with better
outcomes.Kidneyandliver transplantscantoleratelongerischemiatimescomparedtothe
heartandlungs,whichrequiremuchfastertransplantation.
Organ Transport: Organs are typically transported via dedicated medical flights or
courierstominimizethetimebetweenharvestingandtransplantation.Insomecases,organs
may be transported across borders, requiring close collaboration between different
transplantcentersandregulatoryagencies.
16.2KidneyandLiverTransplantProcedures
Kidneyandlivertransplantsaretwoofthemostcommonandsuccessfulformsoforgantransplantation.
Theseprocedureshavesignificantlyimprovedthesurvivalandqualityoflifeforpatientssufferingfrom
end-stagerenalandliverdisease.Thissectioncoversthesurgicaltechniques,indications,andoutcomes
forkidneyandlivertransplants.
16.2.1KidneyTransplantation
Kidneytransplantationisthetreatmentofchoiceforpatientswithend-stagerenaldisease(ESRD),which
canresultfromconditionssuchas chronic glomerulonephritis, polycystic kidneydisease, diabetes,and
hypertension.Itisconsideredmorecost-effectiveandprovidesbetterlong-termoutcomesthandialysis.
https://t.me/med1917
16.2.1.1IndicationsforKidneyTransplantation
PatientswithESRDaregenerallyconsideredforkidneytransplantationwhen:
Theyhaveaglomerularfiltrationrate(GFR)oflessthan15mL/min.
Theyareonchronicdialysis(hemodialysisorperitonealdialysis).
They meet the necessary criteria for transplant, including good general health apart from
kidney failure, no active infections or malignancies, and compliance with treatment
protocols.
16.2.1.2SurgicalTechniquesforKidneyTransplantation
Kidney transplantation involves placing a healthy kidney from a living or deceased donor into the
recipient’slower abdomen.Therecipient’sdiseased kidneysare usuallyleftin place unless thereis a
specificreasontoremovethem(e.g.,recurrentinfectionsorcancer).
Donor Kidney Preparation: The donor kidney is removed via a laparoscopic or open
procedure and perfused with a cold preservation solution. After ensuring the kidney's
viability,itisstoredinasterilecontaineratatemperatureof4°Cuntiltransplantation.
RecipientSurgery:Thekidneyisimplantedintotheiliacfossa,andthedonorrenalartery
is connectedtotherecipient’siliacarteryor externaliliac artery. Thedonorrenal veinis
anastomosed to the recipient’s iliac vein. Lastly, the donor ureter is attached to the
recipient’sbladdertoensureurinarydrainage.
Postoperative Care: After surgery, the patient is closely monitored for signs of kidney
function,electrolytebalance, andpotential complicationssuchas bleeding,thrombosis, or
rejection. Immunosuppressive therapyis started immediatelyto prevent rejection,andthe
patientisusuallydischargedwithinonetotwoweeks.
16.2.1.3LivingDonorKidneyTransplant
Livingdonorkidneytransplantsarepreferredduetothebetteroutcomesassociatedwiththeshortercold
ischemia time and higher organ quality. Living donors undergo rigorous evaluation to ensure they are
healthyenoughtodonate.Donorscanbegeneticallyrelatedorunrelatedtotherecipient.
16.2.1.4ComplicationsofKidneyTransplantation
Whilekidneytransplantationhasahighsuccessrate,complicationscanoccur.Theseinclude:
Rejection:Acuteandchronicrejectionarethemostsignificantconcerns,requiringlifelong
immunosuppressiontopreventorganrejection.
Infections: Immunosuppressive therapy increases the risk of infections, particularlyviral
infections such as cytomegalovirus (CMV) and bacterial infections like urinary tract
infections(UTIs).
Post-Transplant Diabetes Mellitus (PTDM): Some patients develop diabetes after
transplantation due to immunosuppressive drugs like corticosteroids and calcineurin
inhibitors.
Recurrence of Original Disease: In some cases, the original kidney disease that led to
https://t.me/med1917
ESRDcanrecurinthetransplantedkidney.
16.2.2LiverTransplantation
Livertransplantationisperformedforpatientswithend-stageliverdisease,acuteliverfailure,orcertain
liver tumors. The liver has a remarkable capacity for regeneration,allowingthe use of living donors
where only a portion of the donor’s liver is transplanted, and both the donor's and recipient’s liver
regenerateovertime.
16.2.2.1IndicationsforLiverTransplantation
Patientswithadvancedliver diseaseoracuteliverfailuremaybe consideredforlivertransplantation.
Commonindicationsinclude:
Cirrhosis:CausedbychronichepatitisBorCinfection,alcoholabuse,non-alcoholicfatty
liverdisease(NAFLD),andautoimmunehepatitis.
Hepatocellular Carcinoma (HCC): Liver transplantation is indicated for patients with
small,unresectablelivertumorswithincertaincriteria(e.g.,theMilancriteria).
Acute Liver Failure: Often caused by viral hepatitis, drug toxicity (e.g., acetaminophen
overdose),orautoimmunehepatitis.
16.2.2.2SurgicalTechniquesforLiverTransplantation
Livertransplantationisatechnicallydemandingsurgery,involvingtheremovalofthediseasedliverand
implantationofthedonorliver.
DonorLiverHarvesting: Theliver is harvested froma living or deceased donor. In the
caseofalivingdonor,onlytherightorleftlobeoftheliverisremoved.
Recipient Surgery: The diseased liver is excised, and the donor liver is placed in the
anatomicalposition.Thedonorhepaticartery,portalvein,andbileductareanastomosedto
therecipient’svesselsandbileduct.Biliarydrainageisacriticalaspectoftheprocedure,
andaT-tubeorbiliarystentmaybeplacedtoensurebileflow.
Postoperative Care: Afterliver transplantation,the patientrequires close monitoringfor
graftfunction,liverenzymes,andcomplicationssuchasbleeding,bileleaks,orthrombosis
ofthehepaticartery.Immunosuppressivetherapyisinitiatedimmediately,andliverfunction
isassessedregularlythroughbloodtestsandimagingstudies.
16.2.2.3LivingDonorLiverTransplantation
Living donor liver transplantation involves the removal of a portion of the donor’s liver, which is
transplantedintotherecipient.Theliver’sregenerativecapacityallowsboththedonorandrecipientto
regain normal liver function within a few months. Living donor liver transplants are particularly
advantageousincountrieswithlongwaitinglistsfordeceaseddonororgans.
16.2.2.4ComplicationsofLiverTransplantation
Complicationsafterlivertransplantationinclude:
PrimaryGraftNon-Function:Thetransplantedlivermayfailtofunction,requiringurgent
https://t.me/med1917
re-transplantation.
VascularComplications:These includehepaticarterythrombosis,portal veinthrombosis,
andbleeding.
BiliaryComplications:Biliarystrictures,leaks,orinfectionsarecommonandmayrequire
endoscopicorsurgicalintervention.
Infections: As with kidney transplantation, immunosuppression increases the risk of
opportunisticinfections,includingCMV,fungalinfections,andbacterialsepsis.
16.3ImmunosuppressionandPost-TransplantCare
Thesuccessofanyorgantransplantationdependsheavilyontheabilitytocontroltherecipient’simmune
responsetotheforeignorgan.Immunosuppressivetherapyiscrucialinpreventingorganrejection,butit
comeswithitsownsetofrisksandcomplications.
16.3.1PrinciplesofImmunosuppression
The goalofimmunosuppressive therapyistopreventtherecipient’simmunesystem fromattackingthe
transplanted organ while minimizing the risk of infections, malignancies, and drug toxicity.
Immunosuppressiveregimenstypicallyinvolve a combinationofdrugsthattargetdifferentpathwaysof
theimmuneresponse.
InductionTherapy:Highdosesofimmunosuppressivedrugsaregivenimmediatelybefore
andafter thetransplanttopreventearlyrejection.Drugsusedininductiontherapyinclude
monoclonal and polyclonal antibodies, such as basiliximab and antithymocyte globulin
(ATG).
MaintenanceTherapy:Long-termimmunosuppressionismaintainedwithacombinationof
drugs, including calcineurin inhibitors (e.g., tacrolimus, cyclosporine), antiproliferative
agents (e.g.,mycophenolatemofetil), andcorticosteroids (e.g., prednisone). These drugs
aretakenforlifetopreventbothacuteandchronicrejection.
MinimizingToxicity: A major challenge in transplant medicineis balancing theneedfor
immunosuppression with the risks of drug toxicity, infections, and malignancies. Regular
monitoring of drug levels, kidney and liver function, and blood counts is essential to
minimizetheserisks.
16.3.2TypesofOrganRejection
Organrejectionoccurswhentherecipient’simmunesystemrecognizesthetransplantedorganasforeign
andmounts animmune response to destroyit. There are several types of rejection,eachwithdistinct
clinicalfeaturesandtreatmentstrategies.
HyperacuteRejection:Occurswithinminutestohoursoftransplantationandiscausedby
preformedantibodiesagainstthedonororgan(usuallyduetoABOorHLAincompatibility).
https://t.me/med1917
It is rare today due to advances in crossmatching and pre-transplant testing but requires
immediateremovalofthetransplantedorganifitoccurs.
AcuteRejection: Occurs days to weeks after transplantationandis mediatedby T-cells.
Symptoms include fever, graft tenderness, anddysfunction ofthe transplanted organ(e.g.,
elevatedcreatinineinkidneytransplants,elevatedliverenzymesinlivertransplants).Acute
rejectioncanoftenbetreatedwithhigh-dosecorticosteroidsorantibodytherapy.
ChronicRejection:Developsmonthstoyearsaftertransplantationandleadstogradualloss
of graft function. The exactcause of chronic rejection is unclear, but it may be due to a
combination of immune-mediated injury and non-immune factors such as ischemia and
infection.Chronicrejectionisdifficulttotreatandmayeventuallyrequirere-transplantation.
16.3.3Post-TransplantMonitoringandComplications
Post-transplantcareinvolvesclosemonitoringforsignsofrejection,infection,andcomplicationsrelated
toimmunosuppression.Regularfollow-upwiththetransplantteamisessential todetectproblemsearly
andadjusttherapyasneeded.
Infections:Immunosuppressedpatientsareathighriskforopportunisticinfections,suchas
CMV, Epstein-Barr virus(EBV),andfungalinfections.Prophylactic antibiotics,antivirals,
andantifungalsareoftengivenduringthefirstfewmonthsaftertransplantationtoreducethe
riskofinfection.
Malignancies: Long-term immunosuppression increases the risk of developing
malignancies, particularly skin cancer and post-transplant lymphoproliferative disorder
(PTLD), which is associated with EBV infection. Regular cancer screening and prompt
treatmentofsuspiciouslesionsarecriticalinpost-transplantcare.
RenalDysfunction:Manyimmunosuppressivedrugs,particularlycalcineurininhibitors,can
cause kidney damage over time. Monitoring kidney function and adjusting drug doses is
essentialtopreventlong-termrenaldysfunctionintransplantrecipients.
16.3.4QualityofLifeandLong-TermCare
Successfulorgantransplantationcandramaticallyimprovethequalityoflifeforrecipients,allowingthem
to return to normal activities and live longer,healthier lives. However, long-term care is essential to
ensurethecontinuedfunctionofthetransplantedorganandmanagethesideeffectsofimmunosuppression.
Patient Education: Transplant recipients must be educated about the importance of
medication adherence, regular follow-up appointments, and lifestyle modifications (e.g.,
maintaining a healthy diet, avoidingsmoking andalcohol, andpracticing good hygiene to
preventinfections).
PsychologicalSupport:Transplantpatientsmayexperiencesignificantpsychologicalstress,
including anxiety about organ rejection, coping with the side effects of medications, and
adjusting to lifeafter surgery. Access to counselingandsupportgroups can help patients
navigatethesechallenges.
Conclusion
https://t.me/med1917
Transplant surgery is one of the most advanced and life-saving fields in medicine, offering hope to
patientswithend-stageorganfailure. Thischapterhasexploredtheprinciples oforgantransplantation,
includingdonorselection,immunologicalcompatibility, andorganpreservation.Ithasalsocoveredthe
surgicaltechniquesforkidneyandlivertransplantation,aswellastheroleofimmunosuppressivetherapy
inpreventingorganrejection.
Thesuccessoftransplantsurgerydependsnotonlyontechnicalexpertisebutalsoonamultidisciplinary
approachthatincludessurgeons,immunologists,transplantcoordinators,andpost-transplantcareteams.
Asadvancementsinimmunosuppressivetherapy,organpreservation,andsurgicaltechniquescontinue,the
futureoftransplantsurgeryholdsgreatpromiseforimprovingpatientoutcomesandexpandingaccessto
life-savingprocedures.
https://t.me/med1917
CHAPTERSEVENTEEN
GlobalSurgeryandHumanitarianWork
Global surgeryis a field thataddresses the critical needfor surgical care inlow- and middle-income
countries (LMICs), where access to essential surgical services is limited. The burden of surgically
treatableconditionsintheseregionsisvast,andalackofinfrastructure,trainedpersonnel, andfunding
contributestohighmorbidityandmortalityrates.Humanitarianworkinglobalsurgeryinvolvesproviding
surgicalcareinresource-poorsettings,ofteninresponsetocrisessuchasnaturaldisasters,conflicts,or
chronichealthcaredisparities.
Thischapterwillexplorethekeytopicsinglobalsurgeryandhumanitarianwork,including:
SurgicalCareinLow-ResourceSettings
GlobalHealthInitiativesandSurgery
EthicsofHumanitarianSurgery
17.1SurgicalCareinLow-ResourceSettings
In many LMICs, access to safe and timely surgical care is severely limited. This can be due to a
combinationoffactors,suchasinadequateinfrastructure,shortagesoftrainedsurgeonsandanesthetists,
andthe prohibitive costs of surgery. Addressingthese issues requires a thorough understanding of the
https://t.me/med1917
challenges and the development of strategies that can be implemented even in resource-constrained
environments.
17.1.1TheBurdenofSurgicalDisease
Theglobalburdenofsurgicaldiseaseissignificant,withanestimated5billionpeoplelackingaccessto
safe,affordable,andtimelysurgical care.This contributes tomillionsof preventable deaths eachyear
fromconditionsthatcouldbetreatedsurgically,suchas:
Trauma: Road traffic accidents, falls, burns, and other injuries often require surgical
intervention.However,manyLMICslackthecapacitytoprovide trauma care,resultingin
highermortalityanddisabilityrates.
Infectious Diseases: Surgical care is sometimes required to manage complications of
infectious diseases, such as abscess drainage, debridement of necrotic tissue, or the
treatmentofconditionslikeosteomyelitisortuberculosis(TB)involvingbonesorthespine.
MaternalHealth: Obstetric complications, such as obstructed labor, uterine rupture, and
postpartumhemorrhage,oftenrequireemergencysurgicalcare,includingcesareansections.
The lack ofaccess toskilledsurgical care isa major factorinthehighrates of maternal
mortalityinLMICs.
Non-CommunicableDiseases(NCDs):Conditionssuchascancer,cardiovasculardiseases,
anddiabetesarebecomingincreasinglyprevalentinLMICs.Manyofthesediseasesrequire
surgical intervention, such as tumor resections or cardiovascular surgeries, yet surgical
servicesareoftenunavailableorinaccessible.
17.1.2ChallengesinProvidingSurgicalCareinLow-ResourceSettings
Therearenumerousbarrierstodeliveringsurgicalcareinlow-resourcesettings.Thesechallengesvary
byregionandareinfluencedbyeconomic,political,andsocialfactors.
17.1.2.1LackofInfrastructureandEquipment
In many LMICs, hospitals and clinics lack the basic infrastructure necessary to support surgical
procedures.Thiscaninclude:
OperatingRooms(ORs): Inadequate or poorlyequippedoperatingroomsare a common
challenge. Many facilities lack essential surgical instruments, sterile environments, and
functioninganesthesiaequipment.Power outages andlimitedaccess tocleanwater further
compromisetheabilitytoprovidesafesurgery.
PostoperativeCareUnits:Theabsenceofadequatelystaffedandequippedpostoperative
care units contributes to higher rates of postoperative complications and mortality. Basic
needs,suchasoxygen,monitoringequipment,andbloodproducts,areoftenunavailable.
Sterilization and Infection Control: In many low-resource settings, maintaining sterile
environments is difficult. The lack of sterilization equipment and poor infection control
practices increase the risk of surgical site infections, leading to higher morbidity and
mortalityrates.
17.1.2.2ShortageofSkilledPersonnel
https://t.me/med1917
Asignificantshortageoftrainedsurgicalpersonnel,includingsurgeons,anesthetists,andnurses,isoneof
thegreatestbarrierstoprovidingsurgicalcareinLMICs.Thisshortageisoftenexacerbatedbythe"brain
drain," where skilled professionals emigrate to high-income countries (HICs) in search of better job
opportunities,leavingthehealthcareworkforceintheirhomecountriesdepleted.
Training and Retention: Many LMICs lack the educational infrastructure to train new
surgeonsandmedical professionals. Additionally,thechallengingworkenvironments,low
pay,andlimitedprofessionaldevelopmentopportunitiesmakeitdifficulttoretainqualified
healthcareworkers.
Task Shifting: To address the shortage of trained surgeons, some countries have
implemented task-shifting strategies, where non-physician clinicians, such as clinical
officers or nurses, are trained to perform basic surgical procedures. While this can help
addresstheimmediateneedforsurgicalcare,italsoraisesconcernsaboutthequalityand
safetyofsurgeryinsuchcontexts.
17.1.2.3FinancialBarrierstoSurgery
Thehigh costofsurgical careisanothersignificantbarrierinLMICs.Evenwhensurgicalservicesare
available,manypatientscannotaffordtheout-of-pocketexpensesassociatedwiththeprocedure,hospital
stay,andpostoperativecare.Thisleadstodelayedcare,withpatientsseekingtreatmentonlywhentheir
conditionbecomeslife-threateningorirreversible.
CatastrophicHealthExpenditure: Surgical costs can pushfamilies intopoverty, as they
mayhavetosellassetsor takeoutloanstocovermedicalexpenses.Thisisreferredtoas
catastrophichealthexpenditure,anditisamajorfactorinhealthinequitiesinLMICs.
Lack of Health Insurance: Many people in LMICs lack access to health insurance that
coverssurgicalcare.Evenwhenpublichealthcaresystemsexist,theyareoftenunderfunded
andunabletomeetthedemandforsurgicalservices.
17.1.3InnovationsandSolutionsforLow-ResourceSurgicalCare
Despitethechallenges,severalinnovativeapproacheshavebeendevelopedtoimproveaccesstosurgical
careinlow-resourcesettings.
17.1.3.1MobileSurgicalUnits
Mobilesurgicalunitshavebeenusedinruralandremoteareastoprovidesurgicalcaretocommunities
thatlackaccesstofixedhealthcare facilities. Theseunitsare equippedwithbasicsurgical instruments,
anesthesiamachines,andsterilizationequipment,allowingteamsofsurgeonsandanesthetiststotravelto
underservedareasandperformsurgeries.
Case Example: In sub-Saharan Africa, mobile surgical units have been successfully
deployedtoprovideessentialsurgicalservices,suchascataractsurgery,herniarepair,and
cesareansections.Theseunitscanbelife-saving,particularlyinregionswherethenearest
hospitalmaybeseveralhoursorevendaysaway.
17.1.3.2Task-ShiftingandTrainingPrograms
Task-shiftinghasbecomeanimportantstrategyinaddressingtheshortageoftrainedsurgeonsinLMICs.
https://t.me/med1917
Соседние файлы в папке @xirurgi_2025